OSLAM syndrome
(Redirected from Osteosarcoma, limb anomalies, and erythroid macrocytosis with megaloblastic marrow)
OSLAM syndrome is a rare genetic disorder characterized by a combination of Osteosarcoma, Limb anomalies, and Meningioma. The acronym OSLAM stands for these primary features of the syndrome. It is a complex condition that affects multiple systems in the body, often leading to significant medical challenges.
Clinical Features[edit | edit source]
Individuals with OSLAM syndrome typically present with the following clinical features:
- **Osteosarcoma**: A type of bone cancer that usually develops in the long bones of the body, such as the arms and legs.
- **Limb anomalies**: These can include a range of abnormalities in the limbs, such as limb length discrepancies, malformations, or underdevelopment.
- **Meningioma**: A type of tumor that forms on the membranes covering the brain and spinal cord.
Genetics[edit | edit source]
OSLAM syndrome is believed to be caused by mutations in specific genes, although the exact genetic basis is not fully understood. It is typically inherited in an autosomal dominant pattern, meaning that a single copy of the altered gene in each cell is sufficient to cause the disorder.
Diagnosis[edit | edit source]
The diagnosis of OSLAM syndrome is based on clinical evaluation, family history, and genetic testing. Imaging studies such as X-ray, MRI, and CT scan are often used to identify the presence of osteosarcoma and meningioma.
Treatment[edit | edit source]
Treatment for OSLAM syndrome is multidisciplinary and may involve:
- **Surgical intervention**: To remove tumors and correct limb anomalies.
- **Chemotherapy and radiation therapy**: For the treatment of osteosarcoma.
- **Rehabilitation**: To address functional impairments due to limb anomalies.
Prognosis[edit | edit source]
The prognosis for individuals with OSLAM syndrome varies depending on the severity of the symptoms and the success of the treatments. Early diagnosis and intervention are crucial for improving outcomes.
Related Pages[edit | edit source]
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD